Glenmark Life science IPO by Mr. Yash Gupta, Angel Broking Ltd
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Below is quote on Glenmark Life science IPO by Mr. Yash Gupta, Equity Research Associate, Angel Broking Ltd
Glenmark Life Sciences Limited (“GLS”) was incorporated on 23rd June 2011. GLS is a wholly-owned subsidiary of the Promoter, Glenmark Pharmaceuticals Ltd. GLS operates two business lines – Generic APIs (generics and complex APIs) and CDMO (including specialty). GLS is a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (“APIs”) in chronic therapeutic areas, including cardiovascular disease (“CVS”), central nervous system disease (“CNS”), pain management and diabetes.
Positives: (a) Good track record of regulatory compliance, company has not received any warning letter since 2015. (b) Leading manufacturer of selected specialized APIs for chronic therapeutic areas like CVS, CNS, diabetes, and pain management. (c) 16 of the 20 largest generic companies globally were customers, maintains a strong relationship with leading global generic companies.
Investment concerns: a) Dependence on Repetitive orders- approximately 69% of their customers were repeat customers. (b) Company will be increasing its capacity by 25% in FY2022 and underutilization will impact the return ratio. (c) Company will require new working capital for the growth as company having a high working capital cycle of 238 days.
Outlook & Valuation: Based on FY-2021 PE of 22x and EV/EBITDA of 12.9x at the upper price band of the IPO price, valuations are slightly better than the peer companies. Similarly, the company has one of the best ROCE of 32.7%. Company has a healthy balance sheet and will be Net Debt free after the IPO. We expect the upcoming expansion plan in Ankleshwar & Dahej will be the next growth driver for the company. We are assigning a “Subscribe” recommendation to the issue.
Above views are of the author and not of the website kindly read disclaimer
Tag News
On the higher side, immediate resistance is seen around 36000 - 36200 levels - Angel One
